Drug Price Trends for NDC 27241-0287

Average Pharmacy Cost for 27241-0287

Drug Name	NDC	Price/Unit ($)	Unit	Date
PROCHLORPERAZINE 10 MG TAB	27241-0287-01	0.23067	EACH	2025-03-19
PROCHLORPERAZINE 10 MG TAB	27241-0287-01	0.21092	EACH	2025-02-19
PROCHLORPERAZINE 10 MG TAB	27241-0287-01	0.19046	EACH	2025-02-12

Best Wholesale Price for NDC 27241-0287

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Prochlorperazine Maleate (NDC 27241-0287)

Prochlorperazine Maleate, identified by the National Drug Code (NDC) 27241-0287, is an important medication in the pharmaceutical landscape. Manufactured by Ajanta Pharma USA Inc., this drug plays a crucial role in treating various conditions, including severe nausea and vomiting. As we delve into the market analysis and price projections for this specific drug, we'll explore various factors that influence its pricing, market trends, and future outlook.

Understanding Prochlorperazine Maleate (NDC 27241-0287)

Prochlorperazine Maleate is an antipsychotic medication that also has antiemetic properties. It's commonly used to treat severe nausea and vomiting, as well as anxiety and schizophrenia in some cases. The specific NDC 27241-0287 refers to the product manufactured by Ajanta Pharma USA Inc., a subsidiary of the Indian pharmaceutical company Ajanta Pharma Limited[8].

Key Features of NDC 27241-0287

• Manufacturer: Ajanta Pharma USA Inc.
• Drug Name: Prochlorperazine Maleate
• Dosage Form: Tablet
• Route of Administration: Oral

Current Market Status

As of 2025, Prochlorperazine Maleate (NDC 27241-0287) maintains an active presence in the pharmaceutical market. Ajanta Pharma USA Inc. has established itself as a significant player in the generic drug market, offering a range of products including this particular medication[8].

Pricing Trends in the Pharmaceutical Industry

To understand the potential price projections for Prochlorperazine Maleate, it's crucial to examine broader industry trends. The pharmaceutical industry is experiencing several key dynamics that influence pricing:

1. Generic Competition: As more generic versions of drugs enter the market, prices tend to decrease due to increased competition.
2. Regulatory Pressures: Government initiatives to control drug prices can significantly impact pricing strategies.
3. Manufacturing Costs: Fluctuations in raw material costs and production expenses can affect drug prices.
4. Market Demand: Changes in the prevalence of conditions treated by a drug can influence its pricing.

"Generic drug prices often decrease by 3-5% annually due to market competition and regulatory pressures." - DrugPatentWatch[2]

Price Erosion in Generic Markets

Generic drugs, like Prochlorperazine Maleate (NDC 27241-0287), typically experience price erosion over time. Industry data suggests that generic drug prices often decrease by 3-5% annually due to market competition and regulatory pressures[2].

Projected Price Trends for Prochlorperazine Maleate (NDC 27241-0287)

Based on industry trends and available data, we can make some projections for the pricing of Prochlorperazine Maleate (NDC 27241-0287) over the next few years:

Short-term Projections (1-2 years)

In the short term, we can expect modest price decreases for Prochlorperazine Maleate. Assuming a conservative 3% annual price erosion:

• 2025: Potential 3% decrease from current price
• 2026: Additional 3% decrease

Medium-term Projections (3-5 years)

As competition in the generic market continues to intensify, we might see slightly larger price decreases:

• 2027-2029: Potential 4-5% annual decrease

Long-term Projections (Beyond 5 years)

Long-term projections are more challenging due to potential market changes, new entrants, or shifts in treatment paradigms. However, barring any significant disruptions, we might expect:

• 2030 and beyond: Continued price erosion, potentially stabilizing at 3-4% annually

Factors Influencing Price Projections

Several factors could influence the price projections for Prochlorperazine Maleate (NDC 27241-0287):

1. Market Competition

The entry of new manufacturers into the market could lead to more rapid price decreases. As more generic versions of Prochlorperazine Maleate become available, competition intensifies, potentially driving prices down faster than projected.

2. Regulatory Changes

Changes in pharmaceutical regulations can significantly impact drug pricing. For instance, the implementation of new pricing policies or changes in reimbursement rates could affect the price of Prochlorperazine Maleate.

3. Manufacturing Costs

Fluctuations in raw material costs, production expenses, or supply chain disruptions could influence the pricing of Prochlorperazine Maleate. If manufacturing costs increase significantly, it could slow down or even reverse the expected price erosion.

4. Therapeutic Advances

The development of new treatments for conditions currently treated by Prochlorperazine Maleate could impact its demand and, consequently, its pricing. If more effective or convenient alternatives emerge, it could lead to decreased demand and potentially steeper price reductions to maintain market share.

5. Global Market Dynamics

As a subsidiary of an Indian pharmaceutical company, Ajanta Pharma USA Inc. may be influenced by global market dynamics. Changes in international trade policies, currency fluctuations, or shifts in global pharmaceutical supply chains could impact the pricing of their products, including Prochlorperazine Maleate.

Market Trends Shaping the Future of Pharmaceuticals

Several key trends are shaping the future of the pharmaceutical industry, which could indirectly impact the market for Prochlorperazine Maleate:

1. Personalized Medicine

The shift towards treatments tailored to individual patients or genetic profiles is revolutionizing healthcare. While Prochlorperazine Maleate is a well-established generic drug, the broader trend towards personalization could influence how it's prescribed and used[7].

2. Digital Therapeutics

The integration of digital technologies in healthcare delivery and drug administration could impact how medications like Prochlorperazine Maleate are prescribed and monitored[7].

3. Sustainability in Drug Manufacturing

There's a growing focus on sustainability in drug manufacturing to reduce environmental impact. This trend could influence production processes and potentially affect costs[7].

4. Biologic Approvals

While not directly related to Prochlorperazine Maleate, the increasing number of biologic drug approvals is shaping the broader pharmaceutical landscape[3].

5. Return of Funding Flow

The anticipated return of funding liquidity, primarily from increased venture capital investments and private equity capital for mergers and acquisitions, could impact the overall pharmaceutical market dynamics[3].

Future Market Scenarios

Looking ahead, several scenarios could unfold that would impact the pricing of Prochlorperazine Maleate (NDC 27241-0287):

1. Status Quo: Continued gradual price erosion in line with current trends.
2. Increased Competition: Entry of new manufacturers leading to more rapid price decreases.
3. Supply Chain Disruptions: Potential price increases if manufacturing or supply chain issues arise.
4. Regulatory Changes: New pricing regulations could lead to more significant price adjustments.
5. Therapeutic Advances: New treatments for conditions currently addressed by Prochlorperazine Maleate could decrease demand, potentially leading to price reductions to maintain market share.

Impact of Policy Changes

Policy changes can significantly impact drug pricing. For instance, the implementation of the BIOSECURE ACT in the United States and potential changes following the 2024 U.S. presidential election could create uncertainties in the pharmaceutical market[3]. While these may not directly target generic drugs like Prochlorperazine Maleate, they could influence overall market dynamics and pricing strategies.

Role of National Drug Code (NDC) Directory

The NDC Directory, maintained by the FDA, plays a crucial role in the pharmaceutical industry. It provides important information about drugs, including their marketing status. However, it's important to note that inclusion in the NDC Directory does not indicate FDA approval or verify the information provided[5].

For Prochlorperazine Maleate (NDC 27241-0287), the NDC Directory provides essential information about its manufacturer, dosage form, and marketing status. This information is valuable for healthcare providers, insurers, and patients in understanding the drug's position in the market.

Considerations for Stakeholders

Various stakeholders in the pharmaceutical industry should consider the following points regarding Prochlorperazine Maleate (NDC 27241-0287):

For Healthcare Providers

• Stay informed about pricing trends to make cost-effective prescribing decisions.
• Be aware of potential alternatives or new treatments that may emerge in the coming years.

For Insurers

• Anticipate potential price changes in formulary planning.
• Consider the impact of broader industry trends on overall pharmaceutical costs.

For Patients

• Be aware that generic drug prices generally trend downwards over time.
• Discuss with healthcare providers about the most cost-effective treatment options.

For Manufacturers

• Plan for continued price competition in the generic market.
• Consider strategies to maintain market share in the face of potential new entrants or alternative treatments.

Key Takeaways

• Prochlorperazine Maleate (NDC 27241-0287) is likely to experience gradual price erosion in line with generic market trends.
• Short-term projections suggest annual price decreases of 3-5%.
• Long-term pricing will depend on factors including market competition, regulatory changes, and technological advancements in drug manufacturing.
• The broader pharmaceutical industry is being shaped by trends such as personalized medicine, digital therapeutics, and a focus on sustainability.
• Policy changes and global market dynamics could significantly impact future pricing scenarios.
• Stakeholders should stay informed about market trends and be prepared for potential changes in the pricing and positioning of Prochlorperazine Maleate.

FAQs

1. Q: How often do generic drug prices typically decrease? A: Generic drug prices often decrease by 3-5% annually due to market competition and regulatory pressures.

2. Q: Does inclusion in the NDC Directory mean a drug is FDA approved? A: No, inclusion in the NDC Directory does not indicate FDA approval or verify the information provided.

3. Q: How might personalized medicine affect drugs like Prochlorperazine Maleate? A: While Prochlorperazine Maleate is a well-established generic drug, the trend towards personalization could influence how it's prescribed and used in the context of individual patient profiles.

4. Q: What factors could lead to price increases for Prochlorperazine Maleate? A: Potential factors include supply chain disruptions, significant increases in manufacturing costs, or major regulatory changes affecting generic drug pricing.

5. Q: How might the development of new treatments impact the market for Prochlorperazine Maleate? A: New treatments for conditions currently addressed by Prochlorperazine Maleate could decrease demand, potentially leading to price reductions to maintain market share.

Sources cited: [2] https://www.drugpatentwatch.com/p/drug-price/ndc/index.php?query=27241-0304 [3] https://www.pharmtech.com/view/pharmapack-reports-key-trends-2025 [5] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [7] https://themedicinemaker.com/business-regulation/trends-and-therapeutic-areas-to-watch-in-2025 [8] https://www.findacode.com/ndc/labelers/Ajanta_Pharma_USA_Inc.--27241